Notice2025-18202

National Cancer Institute; Notice of Meeting

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
September 19, 2025

Issuing agencies

Health and Human Services DepartmentNational Institutes of Health

Full Text

<html>
<head>
<title>Federal Register, Volume 90 Issue 180 (Friday, September 19, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 180 (Friday, September 19, 2025)]
[Notices]
[Page 45230]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-18202]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the National Cancer 
Advisory Board Ad hoc Working Group on Extramural Research Concepts and 
Programs.
    The meeting will be held as a virtual meeting and is open to the 
public as indicated below. Individuals who plan to view the virtual 
meeting and need special assistance or other reasonable accommodations 
to view the meeting should notify the Contact Person listed below in 
advance of the meeting. Registration is not required. The meeting can 
be accessed from the NIH Videocast at the following link: <a href="https://videocast.nih.gov/watch=57041">https://videocast.nih.gov/watch=57041</a>.

    Name of Committee: National Cancer Advisory Board Ad hoc Working 
Group on Extramural Research Concepts and Programs.
    Date: October 15, 2025.
    Open: 1:00 p.m. to 3:00 p.m.
    Agenda: Concept and Program Review.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Samantha L. Finstad, Ph.D., Program Director, 
Office of the Director, National Cancer Institute--Shady Grove, 
National Institutes of Health, Bethesda Campus/31 11A30B, Bethesda, 
MD 20892, 240-276-6460, <a href="/cdn-cgi/l/email-protection#b4c7d5d9d5dac0dcd59ad2dddac7c0d5d0f4dadddc9ad3dbc2"><span class="__cf_email__" data-cfemail="8bf8eae6eae5ffe3eaa5ede2e5f8ffeaefcbe5e2e3a5ece4fd">[email&#160;protected]</span></a>.

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page:NCAB: <a href="http://cancer.gov">cancer.gov</a>, where an agenda and any additional 
information for the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

     Dated: September 17, 2025.
Zieta M. Charles,
Program Analyst,Office of Federal Advisory Committee Policy.
[FR Doc. 2025-18202 Filed 9-18-25; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on September 19, 2025.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.